Evommune (EVMN) IPO deck
Evommune is a clinical-stage biotech company developing innovative therapies that target the underlying drivers of chronic inflammatory diseases.
Evommune is a clinical-stage biotech company developing innovative therapies that target the underlying drivers of chronic inflammatory diseases.
%20IPO%20deck){kind=link}